Moderna, Inc. Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Moderna, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Moderna, Inc. for March 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 121.07 | 4,888 | 591,810 | 9,116,657 | 9.1 M to 9.1 M (-0.05 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 123.44 | 1,000 | 123,440 | 9,121,545 | 9.1 M to 9.1 M (-0.01 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 123.08 | 31,943 | 3,931,538 | 9,122,545 | 9.2 M to 9.1 M (-0.35 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 121.71 | 14,379 | 1,750,038 | 9,154,488 | 9.2 M to 9.2 M (-0.16 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 120.76 | 225,732 | 27,259,283 | 9,168,867 | 9.4 M to 9.2 M (-2.40 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 119.81 | 344,542 | 41,278,061 | 9,394,599 | 9.7 M to 9.4 M (-3.54 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 118.90 | 611,922 | 72,758,505 | 9,739,141 | 10.4 M to 9.7 M (-5.91 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 118.04 | 883,277 | 104,265,815 | 10,351,063 | 11.2 M to 10.4 M (-7.86 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 131.30 | 558 | 73,265 | 11,234,340 | 11.2 M to 11.2 M (0.00 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 130.56 | 6,610 | 862,994 | 11,234,898 | 11.2 M to 11.2 M (-0.06 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 129.54 | 83,242 | 10,783,377 | 11,241,508 | 11.3 M to 11.2 M (-0.74 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 128.74 | 123,374 | 15,883,527 | 11,324,750 | 11.4 M to 11.3 M (-1.08 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 127.47 | 46,872 | 5,974,788 | 11,448,124 | 11.5 M to 11.4 M (-0.41 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 126.40 | 82,557 | 10,434,924 | 11,494,996 | 11.6 M to 11.5 M (-0.71 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 125.36 | 116,383 | 14,589,226 | 11,577,553 | 11.7 M to 11.6 M (-1.00 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 124.42 | 251,545 | 31,296,927 | 11,693,936 | 11.9 M to 11.7 M (-2.11 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 123.50 | 639,681 | 78,998,365 | 11,945,481 | 12.6 M to 11.9 M (-5.08 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 122.54 | 284,300 | 34,836,672 | 12,585,162 | 12.9 M to 12.6 M (-2.21 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 134.72 | 500 | 67,360 | 99,430 | 99.9 K to 99.4 K (-0.50 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 134.10 | 3,200 | 429,120 | 99,930 | 103.1 K to 99.9 K (-3.10 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 133.06 | 3,006 | 399,978 | 103,130 | 106.1 K to 103.1 K (-2.83 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 132.04 | 2,915 | 384,897 | 106,136 | 109.1 K to 106.1 K (-2.67 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 130.73 | 700 | 91,511 | 109,051 | 109.8 K to 109.1 K (-0.64 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 129.40 | 300 | 38,820 | 109,751 | 110.1 K to 109.8 K (-0.27 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 128.89 | 425 | 54,778 | 110,051 | 110.5 K to 110.1 K (-0.38 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 599,822 | |
Mar 30 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 130.05 | 5,000 | 650,250 | 0 | 5 K to 0 (-100.00 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Mar 26 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 126.88 | 10,000 | 1,268,800 | 7,484,880 | 7.5 M to 7.5 M (-0.13 %) |
Mar 26 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 2,000 | 0 | 6,389,868 | 6.4 M to 6.4 M (-0.03 %) |
Mar 26 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 137.07 | 9,000 | 1,233,630 | 6,391,868 | 6.4 M to 6.4 M (-0.14 %) |
Mar 26 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 172,676 | |
Mar 26 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 126.88 | 6,600 | 837,408 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 26 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 10.90 | 5,000 | 54,500 | 346,972 | |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 10.90 | 5,000 | 54,500 | 351,972 | |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 557,431 | |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 137.07 | 5,000 | 685,350 | 1,609,597 | 1.6 M to 1.6 M (-0.31 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 10.90 | 5,000 | 54,500 | 1,614,597 | 1.6 M to 1.6 M (+0.31 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 145.50 | 5,800 | 843,900 | 1,609,597 | 1.6 M to 1.6 M (-0.36 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 144.19 | 286 | 41,238 | 1,615,397 | 1.6 M to 1.6 M (-0.02 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 143.44 | 600 | 86,064 | 1,615,683 | 1.6 M to 1.6 M (-0.04 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 141.98 | 859 | 121,961 | 1,616,283 | 1.6 M to 1.6 M (-0.05 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 141.22 | 1,100 | 155,342 | 1,617,142 | 1.6 M to 1.6 M (-0.07 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 140.16 | 1,702 | 238,552 | 1,618,242 | 1.6 M to 1.6 M (-0.11 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 139.19 | 1,873 | 260,703 | 1,619,944 | 1.6 M to 1.6 M (-0.12 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 138.25 | 2,139 | 295,717 | 1,621,817 | 1.6 M to 1.6 M (-0.13 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 136.96 | 641 | 87,791 | 1,623,956 | 1.6 M to 1.6 M (-0.04 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,624,597 | 1.6 M to 1.6 M (+0.62 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 10.90 | 5,000 | 54,500 | 1,614,597 | 1.6 M to 1.6 M (+0.31 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 604,822 | |
Mar 25 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 137.07 | 5,000 | 685,350 | 0 | 5 K to 0 (-100.00 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Mar 23 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 20.93 | 1,199 | 25,095 | 169,599 | |
Mar 23 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 147.50 | 61 | 8,998 | 0 | 61 to 0 (-100.00 %) |
Mar 23 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 146.46 | 290 | 42,473 | 61 | 351 to 61 (-82.62 %) |
Mar 23 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 145.47 | 227 | 33,022 | 351 | 578 to 351 (-39.27 %) |
Mar 23 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 144.06 | 366 | 52,726 | 578 | 944 to 578 (-38.77 %) |
Mar 23 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 142.83 | 255 | 36,422 | 944 | 1.2 K to 944 (-21.27 %) |
Mar 23 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 20.93 | 1,199 | 25,095 | 1,199 | 0 to 1.2 K |
Mar 23 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 609,822 | |
Mar 23 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 144.19 | 5,000 | 720,950 | 0 | 5 K to 0 (-100.00 %) |
Mar 23 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Mar 23 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 144.12 | 456 | 65,719 | 110,476 | 110.9 K to 110.5 K (-0.41 %) |
Mar 23 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 143.27 | 5,330 | 763,629 | 110,932 | 116.3 K to 110.9 K (-4.58 %) |
Mar 23 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 142.35 | 3,160 | 449,826 | 116,262 | 119.4 K to 116.3 K (-2.65 %) |
Mar 23 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 141.30 | 1,800 | 254,340 | 119,422 | 121.2 K to 119.4 K (-1.48 %) |
Mar 23 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 140.11 | 300 | 42,033 | 121,222 | 121.5 K to 121.2 K (-0.25 %) |
Mar 19 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 216 | 4,521 | 185,876 | |
Mar 19 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 25.93 | 6,384 | 165,537 | 118,155 | |
Mar 19 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 144.39 | 6,600 | 952,974 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 19 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 216 | 4,521 | 7,501 | 7.3 K to 7.5 K (+2.96 %) |
Mar 19 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 25.93 | 6,384 | 165,537 | 7,285 | 901 to 7.3 K (+708.55 %) |
Mar 19 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 144.39 | 10,000 | 1,443,900 | 7,494,880 | 7.5 M to 7.5 M (-0.13 %) |
Mar 19 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 2,000 | 0 | 6,400,868 | 6.4 M to 6.4 M (-0.03 %) |
Mar 19 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 149.78 | 9,000 | 1,348,020 | 6,402,868 | 6.4 M to 6.4 M (-0.14 %) |
Mar 18 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 25.93 | 6,600 | 171,138 | 124,539 | |
Mar 18 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 148.50 | 6,600 | 980,100 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 18 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 25.93 | 6,600 | 171,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Mar 18 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 614,822 | |
Mar 18 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 149.78 | 5,000 | 748,900 | 0 | 5 K to 0 (-100.00 %) |
Mar 18 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Mar 16 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 14.22 | 34 | 483 | 40,141 | |
Mar 16 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 20.93 | 10,000 | 209,300 | 170,798 | |
Mar 16 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 143.09 | 957 | 136,937 | 0 | 957 to 0 (-100.00 %) |
Mar 16 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 142.17 | 2,101 | 298,699 | 957 | 3.1 K to 957 (-68.71 %) |
Mar 16 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 141.31 | 2,988 | 422,234 | 3,058 | 6 K to 3.1 K (-49.42 %) |
Mar 16 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 140.38 | 1,874 | 263,072 | 6,046 | 7.9 K to 6 K (-23.66 %) |
Mar 16 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 139.09 | 300 | 41,727 | 7,920 | 8.2 K to 7.9 K (-3.65 %) |
Mar 16 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 138.26 | 602 | 83,233 | 8,220 | 8.8 K to 8.2 K (-6.82 %) |
Mar 16 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 137.00 | 801 | 109,737 | 8,822 | 9.6 K to 8.8 K (-8.32 %) |
Mar 16 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 136.00 | 411 | 55,896 | 9,623 | 10 K to 9.6 K (-4.10 %) |
Mar 16 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 14.22 | 34 | 483 | 10,034 | 10 K to 10 K (+0.34 %) |
Mar 16 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 20.93 | 10,000 | 209,300 | 10,000 | 0 to 10 K |
Mar 16 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 619,822 | |
Mar 16 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 137.00 | 5,000 | 685,000 | 0 | 5 K to 0 (-100.00 %) |
Mar 16 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Mar 15 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 137.43 | 800 | 109,944 | 121,522 | 122.3 K to 121.5 K (-0.65 %) |
Mar 15 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 136.65 | 2,891 | 395,055 | 122,322 | 125.2 K to 122.3 K (-2.31 %) |
Mar 15 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 135.67 | 4,025 | 546,072 | 125,213 | 129.2 K to 125.2 K (-3.11 %) |
Mar 15 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 134.60 | 3,330 | 448,218 | 129,238 | 132.6 K to 129.2 K (-2.51 %) |
Mar 12 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 133.29 | 10,000 | 1,332,900 | 7,504,880 | 7.5 M to 7.5 M (-0.13 %) |
Mar 12 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 2,000 | 0 | 6,411,868 | 6.4 M to 6.4 M (-0.03 %) |
Mar 12 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 133.24 | 9,000 | 1,199,160 | 6,413,868 | 6.4 M to 6.4 M (-0.14 %) |
Mar 12 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 25.93 | 6,600 | 171,138 | 131,139 | |
Mar 12 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 133.29 | 6,600 | 879,714 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 12 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 25.93 | 6,600 | 171,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Mar 11 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 624,822 | |
Mar 11 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 133.24 | 5,000 | 666,200 | 0 | 5 K to 0 (-100.00 %) |
Mar 11 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Mar 11 2021 | MRNA | Moderna, Inc. | NABEL ELIZABETH G | Director | Option Exercise | A | 129.75 | 1,139 | 147,785 | 1,139 | |
Mar 11 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 624,822 | |
Mar 11 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 133.24 | 5,000 | 666,200 | 0 | 5 K to 0 (-100.00 %) |
Mar 11 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Mar 11 2021 | MRNA | Moderna, Inc. | NABEL ELIZABETH G | Director | Option Exercise | A | 129.75 | 1,139 | 147,785 | 1,139 | |
Mar 10 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 25.93 | 6,600 | 171,138 | 137,739 | |
Mar 10 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 127.11 | 6,600 | 838,926 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 25.93 | 6,600 | 171,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 629,822 | |
Mar 10 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 129.41 | 5,000 | 647,050 | 0 | 5 K to 0 (-100.00 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 14.22 | 5,000 | 71,100 | 40,175 | |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 1,478 | 18,046 | 0 | |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 20.93 | 10,000 | 209,300 | 180,798 | |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 132.91 | 471 | 62,601 | 0 | 471 to 0 (-100.00 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 131.83 | 2,000 | 263,660 | 471 | 2.5 K to 471 (-80.94 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 130.76 | 2,611 | 341,414 | 2,471 | 5.1 K to 2.5 K (-51.38 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 129.80 | 2,312 | 300,098 | 5,082 | 7.4 K to 5.1 K (-31.27 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 128.62 | 2,698 | 347,017 | 7,394 | 10.1 K to 7.4 K (-26.73 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 127.73 | 1,855 | 236,939 | 10,092 | 11.9 K to 10.1 K (-15.53 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 126.75 | 1,350 | 171,113 | 11,947 | 13.3 K to 11.9 K (-10.15 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 125.68 | 1,361 | 171,050 | 13,297 | 14.7 K to 13.3 K (-9.29 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 124.35 | 273 | 33,948 | 14,658 | 14.9 K to 14.7 K (-1.83 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 123.48 | 1,547 | 191,024 | 14,931 | 16.5 K to 14.9 K (-9.39 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 14.22 | 5,000 | 71,100 | 16,478 | 11.5 K to 16.5 K (+43.56 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 1,478 | 18,046 | 11,478 | 10 K to 11.5 K (+14.78 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 20.93 | 10,000 | 209,300 | 10,000 | 0 to 10 K |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 133.50 | 100 | 13,350 | 132,568 | 132.7 K to 132.6 K (-0.08 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 132.56 | 643 | 85,236 | 132,668 | 133.3 K to 132.7 K (-0.48 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 131.35 | 1,558 | 204,643 | 133,311 | 134.9 K to 133.3 K (-1.16 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 130.43 | 2,325 | 303,250 | 134,869 | 137.2 K to 134.9 K (-1.69 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 129.22 | 1,370 | 177,031 | 137,194 | 138.6 K to 137.2 K (-0.99 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 128.46 | 1,050 | 134,883 | 138,564 | 139.6 K to 138.6 K (-0.75 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 127.40 | 900 | 114,660 | 139,614 | 140.5 K to 139.6 K (-0.64 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 125.63 | 300 | 37,689 | 140,514 | 140.8 K to 140.5 K (-0.21 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 124.37 | 500 | 62,185 | 140,814 | 141.3 K to 140.8 K (-0.35 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 123.50 | 1,500 | 185,250 | 141,314 | 142.8 K to 141.3 K (-1.05 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 122.10 | 800 | 97,680 | 142,814 | 143.6 K to 142.8 K (-0.56 %) |
Mar 05 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 25.93 | 6,600 | 171,138 | 144,339 | |
Mar 05 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 128.58 | 6,600 | 848,628 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 05 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 25.93 | 6,600 | 171,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Mar 05 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 128.58 | 10,000 | 1,285,800 | 7,514,880 | 7.5 M to 7.5 M (-0.13 %) |
Mar 05 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 2,000 | 0 | 6,422,868 | 6.4 M to 6.4 M (-0.03 %) |
Mar 05 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 145.60 | 9,000 | 1,310,400 | 6,424,868 | 6.4 M to 6.4 M (-0.14 %) |
Mar 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 577,431 | |
Mar 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 587,431 | |
Mar 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 145.60 | 10,000 | 1,456,000 | 1,609,597 | 1.6 M to 1.6 M (-0.62 %) |
Mar 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,619,597 | 1.6 M to 1.6 M (+0.62 %) |
Mar 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 153.77 | 10,000 | 1,537,700 | 1,609,597 | 1.6 M to 1.6 M (-0.62 %) |
Mar 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,619,597 | 1.6 M to 1.6 M (+0.62 %) |
Mar 04 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 634,822 | |
Mar 04 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 145.60 | 5,000 | 728,000 | 0 | 5 K to 0 (-100.00 %) |
Mar 04 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Mar 04 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 25.93 | 6,600 | 171,138 | 150,939 | |
Mar 04 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 153.77 | 6,600 | 1,014,882 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 04 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 25.93 | 6,600 | 171,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Mar 02 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 639,822 | |
Mar 02 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 153.84 | 5,000 | 769,200 | 0 | 5 K to 0 (-100.00 %) |
Mar 02 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Mar 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 159.59 | 100 | 15,959 | 143,614 | 143.7 K to 143.6 K (-0.07 %) |
Mar 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 158.15 | 900 | 142,335 | 143,714 | 144.6 K to 143.7 K (-0.62 %) |
Mar 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 157.13 | 500 | 78,565 | 144,614 | 145.1 K to 144.6 K (-0.34 %) |
Mar 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 155.74 | 2,680 | 417,383 | 145,114 | 147.8 K to 145.1 K (-1.81 %) |
Mar 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 154.78 | 1,910 | 295,630 | 147,794 | 149.7 K to 147.8 K (-1.28 %) |
Mar 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 153.65 | 2,986 | 458,799 | 149,704 | 152.7 K to 149.7 K (-1.96 %) |
Mar 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 152.76 | 1,270 | 194,005 | 152,690 | 154 K to 152.7 K (-0.82 %) |
Mar 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 151.67 | 700 | 106,169 | 153,960 | 154.7 K to 154 K (-0.45 %) |